ArticleScientific reports2026
Self-efficacy and quality of life mediate self-reported mental health outcomes in visual snow syndrome.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Visual snow syndrome as a neuropsychiatric network disorder: clinical features, mechanisms, and therapeutic perspectives.Journal of neurology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Visual snow syndrome (VSS) is a chronic neurological disorder associated with impaired mental health. While self-efficacy and quality of life (QOL) are known to influence mental health outcomes (depression and suicidal ideation) in clinical populations, their roles in VSS remain unexplored. This study aimed to examine the associations among VSS, self-efficacy, QOL, mental health outcomes and the potential serial mediation roles of self-efficacy and QOL. A cross-sectional study compared 64 VSS patients and 67 healthy controls matched with age, sex and education level. Participants completed validated questionnaires assessing self-efficacy (GSES), QOL (WHOQOL-BREF), depression (CES-D), and suicidal ideation (BSSI, first five items). Analyses included group comparisons, correlation analyses to examine variable relationships, multimodel linear regression and serial mediation modeling to test the hypothesized sequential pathway from VSS through self-efficacy and quality of life to mental health outcomes. Compared with controls, VSS patients demonstrated significantly lower self-efficacy (VSS: 23.6 ± 6.2; Controls: 30.6 ± 6.0; p < 0.001) and QOL (VSS: 62.5 ± 9.5; Controls: 73.6 ± 8.8; p < 0.001), alongside elevated depression (median [IQR]: VSS: 28 [21,34]; Controls: 11 [7, 15]; p < 0.001) and suicidal ideation (VSS: 6 [5, 7]; Controls: 5 [5,6]; p < 0.01). Serial mediation analysis revealed that the effects of VSS on depression and suicidal ideation were mediated through self-efficacy and QOL sequentially. The total indirect effect for depression was 7.73 (95% CI [5.64-9.85]), with QOL accounting for 49.09% of the total effect. For suicidal ideation, the total indirect effect was 0.80 (95% CI [0.39-1.22]). Lower self-efficacy and QOL appear to serially mediate the associations between VSS and mental health impairments. These preliminary, cross-sectional findings indicate that self-efficacy and QOL may serve as modifiable intervention targets that mediate or moderate the risk of depression and suicidal ideation in individuals with VSS. Clinicians should prioritize routine assessments of these factors to guide early intervention strategies, although longitudinal studies are needed to confirm these causal pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.